Study to Assess the Safety and Efficacy of the IUB SEAD™ Device

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

June 30, 2022

Study Completion Date

December 31, 2022

Conditions

Abnormal Uterine Bleeding

Interventions

DEVICE

SEAD treatment

up to two 30-min endometrial ablation sessions using the IUB SEAD™ device, in a hospital outpatient clinic

Trial Locations (1)

Sheynovo medical center, Sofia

All Listed Sponsors

lead

Ocon Medical Ltd.

INDUSTRY

NCT04381416 - Study to Assess the Safety and Efficacy of the IUB SEAD™ Device | Biotech Hunter | Biotech Hunter